Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NCJournal of Korean medical science

Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort

  • Hyo Jung Cho1
  • Seong Hee Kang2
  • Hye Yeon Chon3
  • SungA Bae4
  • Eunju Kim5
  • Seong Kyun Na6
  • Su Jin Kim7
  • Dooyeon Kim7
  • Hye Ri Ahn1
  • Huigyeong Kim1
  • Jae Youn Cheong1
  • Soon Koo Baik8
3 more authors
  • Young Kul Jung2
  • Soon Sun Kim1
  • Hyung Joon Yim2
8 affiliations
  1. 1Department of Gastroenterology, Ajou University School of Medicine, Suwon, .
  2. 2Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul, .
  3. 3Department of Gastroenterology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, .
  4. 4Department of Cardiology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, .
  5. 5Department of Gastroenterology, Chung-Ang University College of Medicine, Seoul, .
  6. 6Department of Internal Medicine, Inje University College of Medicine, Gimhae, .
  7. 7Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, .
  8. 8Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, .
Read full textPDFCite

Related

  1. Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality
    Marlene Hintersteininger, Benedikt Silvester Hofer, Clemens Renhardt +12
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study
    P. Deb, D. Bagar, P. Kumar +10
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  3. Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
    Michihiro Iwaki, Hiroshi Tobita, Yuya Seko +38
    eClinicalMedicinePeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  4. Short-Term Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Related Circulating Biomarkers Following a Very-Low Calorie Ketogenic Diet (VLCKD): A Paired Longitudinal Analysis
    Rossella Tatoli, Rossella Donghia, Pasqua Letizia Pesole +6
    NutrientsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  5. Circulating MicroRNAs Reflect Systemic Inflammation and Metabolic Dysfunction in Oesophageal Squamous Cell Carcinoma-Associated Cachexia.
    Yan Li, Rui Chen, Xinyi Lv +3
    Journal of cachexia, sarcopenia and musclePeer-reviewedCC BYFull textOncologyEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{cho2026circulating,
  title = {{Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort}},
  author = {Hyo Jung Cho and Seong Hee Kang and Hye Yeon Chon and SungA Bae and Eunju Kim and Seong Kyun Na and Su Jin Kim and Dooyeon Kim and Hye Ri Ahn and Huigyeong Kim and Jae Youn Cheong and Soon Koo Baik and Young Kul Jung and Soon Sun Kim and Hyung Joon Yim},
  journal = {Journal of Korean medical science},
  year = {2026},
  month = jun,
  url = {https://europepmc.org/article/PMC/PMC13730648},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort
AU  - Hyo Jung Cho
AU  - Seong Hee Kang
AU  - Hye Yeon Chon
AU  - SungA Bae
AU  - Eunju Kim
AU  - Seong Kyun Na
AU  - Su Jin Kim
AU  - Dooyeon Kim
AU  - Hye Ri Ahn
AU  - Huigyeong Kim
AU  - Jae Youn Cheong
AU  - Soon Koo Baik
AU  - Young Kul Jung
AU  - Soon Sun Kim
AU  - Hyung Joon Yim
PY  - 2026
DA  - 2026/06/19
JO  - Journal of Korean medical science
UR  - https://europepmc.org/article/PMC/PMC13730648
SN  - 1598-6357
ER  -